Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Laborium Biopharma is a Brazilian pharmaceutical company specializing in the development, production, and commercialization of high-complexity medicines, with a strong focus on biotechnology and oncology. The company is a significant participant in Brazil's Partnerships for Productive Development (PDP) program, collaborating with public laboratories and international technology providers to internalize the production of strategic biopharmaceuticals. Its portfolio includes biosimilars for autoimmune diseases and oncology, as well as specialized small molecule therapies for hematology and rare diseases. Laborium Biopharma aims to expand access to advanced treatments within the Brazilian Unified Health System (SUS) through local manufacturing and technology transfer. The company is headquartered in São Paulo and plays a vital role in the Brazilian Economic-Industrial Health Complex.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Laborium Biopharma.